• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these medications can affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to adhd medication for women medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it versus the dangers for the baby. Physicians don't have the data needed to make unequivocal recommendations, but they can provide information about risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at higher risk of fetal malformations or structural birth defects. The researchers used a large population-based study of case-control to assess the risk of major structural birth defects in infants born to mothers who took stimulants during early pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure an accurate case classification and to limit the chance of bias.

The research conducted by the researchers had some limitations. The most important issue was that they were unable to separate the effects of the medication from the effects of the disorder that is underlying. That limitation makes it difficult to know whether the limited associations observed in the groups that were exposed result from medication use or the confounding effect of comorbidities. In addition, the researchers did not look at the long-term outcomes of offspring.

The study did show that babies whose mothers had taken adhd medication pregnancy, http://polimentosroberto.com.br/index.php?option=com_k2&view=itemlist&task=user&id=4868287, medications during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the higher risk of admission did not appear to be influenced by the stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These risks did not appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit to both mother and child of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, where they are able, assist them in developing strategies to improve their coping abilities that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or stop treatment during pregnancy is a question that more and more physicians confront. Often, these decisions are taken in the absence of any evidence that is clear and definitive regardless, so doctors have to weigh their experience, the experiences of other doctors, and what the research suggests about the subject and their best judgment for each patient.

The issue of possible risks to infants is extremely difficult. The research on this subject is based on observations rather than controlled studies, and many of the findings are contradictory. The majority of studies focus on live births, which may underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study discussed in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion: While some studies have shown a positive correlation between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. The majority of studies show that there is a neutral, or somewhat negative, impact. As a result, a careful risk/benefit analysis must be conducted in every instance.

It can be challenging, if not impossible for women suffering from ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication intuniv medications during pregnancy can cause depression and feelings of loneliness. The loss of medication can also impact the ability to safely drive and complete work-related tasks, which are crucial aspects of daily life for those suffering from ADHD.

She suggests women who are uncertain about whether to keep or discontinue medication due to their pregnancy, consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily life, and the benefits of keeping the current treatment regimen. In addition, educating them can aid in ensuring that the woman feels supported as she struggles with her decision. Certain medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it's important to be aware that the medication may be transferred to her infant.

Birth Defects and Risk of

As the use and abuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Researchers used two massive datasets to analyze over 4.3 million pregnancy and determine if stimulant medication use increased birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The researchers of the study could not discover any link between early use of medication and other congenital anomalies, such as facial deformities or club feet. The results are in line with previous studies showing an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications before the birth of their child. The risk increased in the latter part of pregnancy, when a lot of women decided to stop taking their medication.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to undergo caesarean section, low Apgar score after delivery and a baby who required help breathing at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could be a contributing factor to these findings.

Researchers hope their research will provide doctors with information when they meet pregnant women. The researchers suggest that while discussing the risks and benefits are important, the decision regarding whether or not to stop medication should be based on the severity of each woman's ADHD symptoms and her needs.

The authors also caution that, while stopping the medication is an alternative, it is not a recommended practice because of the high rate of depression and other mental health issues among women who are pregnant or recently post-partum. Additionally, research suggests that women who stop taking their medication will have a tough transitioning to life without them once the baby is born.

Nursing

The responsibilities of being a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments, preparing for the arrival of a child and adapting to new routines in the home are often faced with a number of difficulties. Many women opt to continue taking their ADHD medication during pregnancy.

The risk to nursing infant is low because the majority of stimulant medication is absorbed through breast milk at low levels. The amount of exposure to medications can vary depending upon the dosage and frequency of administration as well as the time of day. In addition, different medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn isn't fully understood.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the lack of research. It's a difficult choice for the woman who must weigh the advantages of continuing her medication against the potential risks to the embryo. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and whether they plan or are taking to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner while breastfeeding and during pregnancy. As a result, many patients opt to do this, and in consultation with their doctor they have found that the benefits of continuing their current medication outweigh any risks.

It's important for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women with adhd medication names for adults be aware of the symptoms and underlying disorder. They should also be informed about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. Counselling for pregnancy should include discussion of a management plan for both the mother and child, monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.